Cost of Cancer Drugs to Force Hard Decisions
June 30th, 2009 Posted by: admin
WHEELING, W.Va. (MedPage Today) — Studies of cancer drugs that are expected to find survival advantages of two months or less should be undertaken only if the treatment costs less than $20,000, two NIH researchers recommended.
Similar Posts:
- Cost of Cancer Drugs to Force Hard Decisions
- Cost of Cancer Drugs to Force Hard Decisions
- Cost of Cancer Drugs to Force Hard Decisions
- ASCO: Maintenance Pemetrexed Extends NSCLC Survival by Three Months
- Epidermoid anal cancer prognosis comparison among HIV+ and HIV− patients
- DNA Drugs for Lupus Show Promise in Mice (CME/CE)
- Slow-Starting Placental Site Tumors Are the Deadliest (CME/CE)
- Slow-Starting Placental Site Tumors Are the Deadliest (CME/CE)
- Slow-Starting Placental Site Tumors Are the Deadliest (CME/CE)
- Cancer Survivors at High Risk for Psychosocial Distress (CME/CE)